| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5846288 | Toxicology and Applied Pharmacology | 2014 | 11 Pages |
Abstract
Combined with our previous findings, KYKZL-1 exhibiting COX/5-LOX inhibition may be a promising potential agent not only for inflammation control but also for cancer prevention/therapy with an enhanced gastric safety profile.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Jing Cheng, Yi-Fang Du, Zhi-Yi Xiao, Li-Li Pan, Wei Li, Lin Huan, Zhu-Nan Gong, Shao-Hua Wei, Shi-Qian Huang, Wei Xun, Yi Zhang, Lei-Lei Chang, Meng-Yu Xie, Gui-Zhen Ao, Jie Cai, Ting Qiu, Hao Wu, Ting Sun, Guang-Lin Xu,